These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24159360)

  • 21. A BioBrick compatible strategy for genetic modification of plants.
    Boyle PM; Burrill DR; Inniss MC; Agapakis CM; Deardon A; DeWerd JG; Gedeon MA; Quinn JY; Paull ML; Raman AM; Theilmann MR; Wang L; Winn JC; Medvedik O; Schellenberg K; Haynes KA; Viel A; Brenner TJ; Church GM; Shah JV; Silver PA
    J Biol Eng; 2012 Jun; 6(1):8. PubMed ID: 22716313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein engineering in the computational age: An open source framework for exploring mutational landscapes
    Bamezai S; Maresca di Serracapriola G; Morris F; Hildebrandt R; Amil MAS; ; Ledesma-Amaro R
    Eng Biol; 2023 Dec; 7(1-4):29-38. PubMed ID: 38094241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Challenges and opportunities for ELSI early career researchers.
    Bell J; Ancillotti M; Coathup V; Coy S; Rigter T; Tatum T; Grewal J; Akcesme FB; Brkić J; Causevic-Ramosevac A; Milovanovic G; Nobile M; Pavlidis C; Finlay T; Kaye J;
    BMC Med Ethics; 2016 Jul; 17(1):37. PubMed ID: 27390930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unraveling the Ethical, Legal, and Social Implications of Neurobiobanking and Stroke Genomic Research in Africa: A Study Protocol of the African Neurobiobank for Precision Stroke Medicine ELSI Project.
    Akinyemi RO; Jenkins C; Nichols M; Singh A; Wahab K; Akpalu A; Sarfo FS; Owolabi LF; Obiako R; Akinyemi J; Ojebuyi B; Adigun M; Musbahu R; Bello A; Titiloye M; Calys-Tagoe B; Ogunronbi M; Uvere E; Laryea R; Fakunle A; Adeleye O; Olorunsogbon O; Ojo A; Adesina D; Mensah N; Oguike W; Coleman N; Mande A; Uthman M; Kalaria RN; Jegede A; Owolabi M; Ovbiagele B; Arulogun O
    Int J Qual Methods; 2020; 19():. PubMed ID: 34276269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implementing adaptive risk management for synthetic biology: Lessons from iGEM's safety and security programme.
    Millett P; Alexanian T
    Eng Biol; 2021 Sep; 5(3):64-71. PubMed ID: 36968257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ethical, Legal, and Social Issues (ELSI) in Clinical Genetics Research.
    Pullman D; Etchegary H
    Methods Mol Biol; 2021; 2249():65-82. PubMed ID: 33871839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ethical, Legal, and Social Implications (ELSI) Research: Methods and Approaches.
    Ogbogu U; Ahmed N
    Curr Protoc; 2022 Jan; 2(1):e354. PubMed ID: 35041252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioethics methods in the ethical, legal, and social implications of the human genome project literature.
    Walker RL; Morrissey C
    Bioethics; 2014 Nov; 28(9):481-90. PubMed ID: 23796275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Student and educator experiences of maternal-child simulation-based learning: a systematic review of qualitative evidence protocol.
    MacKinnon K; Marcellus L; Rivers J; Gordon C; Ryan M; Butcher D
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):14-26. PubMed ID: 26447004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical genetic research 3: Genetics ELSI (Ethical, Legal, and Social Issues) research.
    Pullman D; Etchegary H
    Methods Mol Biol; 2015; 1281():369-82. PubMed ID: 25694322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Standardization in synthetic biology.
    Müller KM; Arndt KM
    Methods Mol Biol; 2012; 813():23-43. PubMed ID: 22083734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ethical, legal, and social issues (ELSI) in rare diseases: a landscape analysis from funders.
    Hartman AL; Hechtelt Jonker A; Parisi MA; Julkowska D; Lockhart N; Isasi R
    Eur J Hum Genet; 2020 Feb; 28(2):174-181. PubMed ID: 31537898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Engineering a novel self-powering electrochemical biosensor.
    Gu X; Trybiło M; Ramsay S; Jensen M; Fulton R; Rosser S; Gilbert D
    Syst Synth Biol; 2010 Sep; 4(3):203-14. PubMed ID: 21189841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthetic biology and the prospects for responsible innovation.
    Macnaghten P; Owen R; Jackson R
    Essays Biochem; 2016 Nov; 60(4):347-355. PubMed ID: 27903822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. We have never been ELSI researchers - there is no need for a post-ELSI shift.
    Myskja BK; Nydal R; Myhr AI
    Life Sci Soc Policy; 2014 Dec; 10():9. PubMed ID: 26085445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Picturing ELSI+: a visual representation of ethical, legal, and social issues, and patient experiences in Health Technology Assessment in Canada.
    Krahn MD; Bielecki JM; Bremner KE; de Oliveira C; Almeida N; Clement F; Lorenzetti DL; O'Campo P; Pechlivanoglou P; Tricco AC
    Int J Technol Assess Health Care; 2020; 36(1):40-49. PubMed ID: 31729308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investing in our nation's future military leaders' synthetic biology knowledge to understand and recognize threats and applications.
    Steel JJ; Bates KL; Barnhart MD
    Synth Biol (Oxf); 2019; 4(1):ysz024. PubMed ID: 33033745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implantable nano-neurotechnological devices: consideration of ethical, legal, and social issues and implications.
    Giordano J; Akhouri R; McBride D
    J Long Term Eff Med Implants; 2009; 19(1):83-93. PubMed ID: 20402632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Engineering a Biological Revolution.
    Matheson S
    Cell; 2017 Jan; 168(3):329-332. PubMed ID: 28129532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.